| Financial Year |
March 31 2023 |
| Monetary Funds |
424,519,511.87 |
| Held-for-trading Financial Assets |
535,493,250.00 |
| Notes Receivable |
229,832.20 |
| Accounts Receivable |
179,262,126.56 |
| Advances to Suppliers |
17,371,696.38 |
| Other Receivables |
14,357,844.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
204,199,785.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,712,085.25 |
| Total Current Assets |
1,386,795,827.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,326,107.67 |
| Investment Properties |
27,718,200.82 |
| Fixed Assetes |
396,620,586.25 |
| Under-construction Projects |
39,068,039.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,734,373.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,016,551.90 |
| Deferred Income Tax Assets |
7,287,469.16 |
| Other Non-Current Assets |
5,568,765.42 |
| Sub-Total of Non-Current Assets |
593,835,013.99 |
| Total Assets |
1,980,630,841.10 |
| Short-Term Loans |
40,027,777.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
116,011,234.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,887,151.82 |
| Taxes Payable |
15,039,472.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,016,670.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
268,140.78 |
| Other Current Liabilities |
1,929,563.68 |
| Sub-Total of Current Liabilities |
230,803,092.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,896,086.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,197,694.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,693,277.39 |
| Total Liabilities |
264,496,369.85 |
| Paid-In Capital(Or Share Stock) |
110,477,500.00 |
| Capital Surplus |
555,837,444.49 |
| Surplus Reserve |
61,469,711.03 |
| LESS:Treasury Stock |
7,195,840.00 |
| Undistributed Profits |
971,767,129.87 |
| Minority Stockholder's Interest |
871,211.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,715,263,259.58 |
| Owner's Equity（Stockholder's Equity） |
1,716,134,471.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,980,630,841.10 |
